Matches in SemOpenAlex for { <https://semopenalex.org/work/W1982504498> ?p ?o ?g. }
- W1982504498 endingPage "S16" @default.
- W1982504498 startingPage "S1" @default.
- W1982504498 abstract "Twelve commercial pyrethroid insecticides (technical-grade active ingredients) were evaluated individually for acute neurobehavioral manifestations of toxicity under conditions suited to assist with determining whether they act by a common mechanism of toxicity. The pyrethroids that were tested reflect a diversity of structures, including six with an alpha-cyano phenoxybenzyl moiety (beta-cyfluthrin, lambda-cyhalothrin, cypermethrin, deltamethrin, esfenvalerate and fenpropathrin) and six without this moiety (bifenthrin, S-bioallethrin, permethrin, pyrethrins, resmethrin and tefluthrin). These chemicals also present a variety of behavioral effects, including ones that are historically classified as causing a T (tremor), CS (choreoathetosis with salivation) or intermediate syndrome of intoxication, and others that have not previously been classified. Each pyrethroid that was tested consisted of the complement of isomers that occur in commercial products--a key factor for relevance for environmental and human exposure and for comparisons, since the biological activity of the individual isomers can vary tremendously. Young-adult male Sprague-Dawley rats (10 per dose group) were administered a single dose of pyrethroid by oral gavage, in corn oil, at a volume of 5 ml/kg. Each was tested at a range of two or three dose levels, including a minimally toxic dose, to establish the more sensitive manifestations of toxicity, and a more toxic dose, to establish a more complete spectrum of neurobehavioral manifestations. Animals were evaluated using a functional observational battery (FOB) that was designed to characterize and distinguish effects classically associated with T or CS syndromes of intoxication. The FOB was performed when manifestations of toxicity were most apparent at the time of peak effect (2, 4, or 8 h post-dosing) by observers who were blinded to dose group assignment, thus avoiding possible bias. The results from this study indicate that some pyrethroids clearly exhibit the historic classification symptoms of the T and CS syndromes while others do so less obviously. Use of the statistical technique of Principal Component Analysis (PCA) further helped interpret the study findings, as described in the accompanying paper (Breckenridge et al., 2009). These results establish manifestations of neurotoxicity in vivo that can be used as weight of evidence to determine whether pyrethroid insecticides act through a common mechanism of toxicity in mammals. Based on a review of the FOB data, analyzed by PCA, and other published data, two common mechanism groups are proposed. Group 1 would include pyrethrins, bifenthrin, resmethrin, permethrin, S-bioallethrin and tefluthrin. Group 2 would include cypermethrin, deltamethrin, esfenvalerate, beta-cyfluthrin and lambda-cyhalothrin. Fenpropathrin exhibited features of both groups." @default.
- W1982504498 created "2016-06-24" @default.
- W1982504498 creator A5006707468 @default.
- W1982504498 creator A5010605775 @default.
- W1982504498 creator A5020096920 @default.
- W1982504498 creator A5069368155 @default.
- W1982504498 creator A5079526462 @default.
- W1982504498 date "2009-11-01" @default.
- W1982504498 modified "2023-10-01" @default.
- W1982504498 title "Comparative functional observational battery study of twelve commercial pyrethroid insecticides in male rats following acute oral exposure" @default.
- W1982504498 cites W1991834773 @default.
- W1982504498 cites W2001959919 @default.
- W1982504498 cites W2003113313 @default.
- W1982504498 cites W2003471890 @default.
- W1982504498 cites W2004100000 @default.
- W1982504498 cites W2005486367 @default.
- W1982504498 cites W2013529252 @default.
- W1982504498 cites W2017663138 @default.
- W1982504498 cites W2022253375 @default.
- W1982504498 cites W2027695518 @default.
- W1982504498 cites W2041767786 @default.
- W1982504498 cites W2051009115 @default.
- W1982504498 cites W2057248618 @default.
- W1982504498 cites W2059217584 @default.
- W1982504498 cites W2059354889 @default.
- W1982504498 cites W2063512792 @default.
- W1982504498 cites W2066033305 @default.
- W1982504498 cites W2067994732 @default.
- W1982504498 cites W2068879317 @default.
- W1982504498 cites W2084328958 @default.
- W1982504498 cites W2084955907 @default.
- W1982504498 cites W2086199571 @default.
- W1982504498 cites W2105595983 @default.
- W1982504498 cites W2108656984 @default.
- W1982504498 cites W2112800018 @default.
- W1982504498 cites W2116920824 @default.
- W1982504498 cites W2119233246 @default.
- W1982504498 cites W2124174369 @default.
- W1982504498 cites W2137002094 @default.
- W1982504498 doi "https://doi.org/10.1016/j.neuro.2009.08.014" @default.
- W1982504498 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19748519" @default.
- W1982504498 hasPublicationYear "2009" @default.
- W1982504498 type Work @default.
- W1982504498 sameAs 1982504498 @default.
- W1982504498 citedByCount "55" @default.
- W1982504498 countsByYear W19825044982012 @default.
- W1982504498 countsByYear W19825044982013 @default.
- W1982504498 countsByYear W19825044982014 @default.
- W1982504498 countsByYear W19825044982015 @default.
- W1982504498 countsByYear W19825044982016 @default.
- W1982504498 countsByYear W19825044982017 @default.
- W1982504498 countsByYear W19825044982018 @default.
- W1982504498 countsByYear W19825044982019 @default.
- W1982504498 countsByYear W19825044982020 @default.
- W1982504498 countsByYear W19825044982021 @default.
- W1982504498 countsByYear W19825044982022 @default.
- W1982504498 countsByYear W19825044982023 @default.
- W1982504498 crossrefType "journal-article" @default.
- W1982504498 hasAuthorship W1982504498A5006707468 @default.
- W1982504498 hasAuthorship W1982504498A5010605775 @default.
- W1982504498 hasAuthorship W1982504498A5020096920 @default.
- W1982504498 hasAuthorship W1982504498A5069368155 @default.
- W1982504498 hasAuthorship W1982504498A5079526462 @default.
- W1982504498 hasConcept C126322002 @default.
- W1982504498 hasConcept C161176658 @default.
- W1982504498 hasConcept C2776035571 @default.
- W1982504498 hasConcept C2777553912 @default.
- W1982504498 hasConcept C2778635518 @default.
- W1982504498 hasConcept C2778727878 @default.
- W1982504498 hasConcept C29730261 @default.
- W1982504498 hasConcept C33070731 @default.
- W1982504498 hasConcept C6557445 @default.
- W1982504498 hasConcept C71924100 @default.
- W1982504498 hasConcept C86803240 @default.
- W1982504498 hasConcept C98274493 @default.
- W1982504498 hasConceptScore W1982504498C126322002 @default.
- W1982504498 hasConceptScore W1982504498C161176658 @default.
- W1982504498 hasConceptScore W1982504498C2776035571 @default.
- W1982504498 hasConceptScore W1982504498C2777553912 @default.
- W1982504498 hasConceptScore W1982504498C2778635518 @default.
- W1982504498 hasConceptScore W1982504498C2778727878 @default.
- W1982504498 hasConceptScore W1982504498C29730261 @default.
- W1982504498 hasConceptScore W1982504498C33070731 @default.
- W1982504498 hasConceptScore W1982504498C6557445 @default.
- W1982504498 hasConceptScore W1982504498C71924100 @default.
- W1982504498 hasConceptScore W1982504498C86803240 @default.
- W1982504498 hasConceptScore W1982504498C98274493 @default.
- W1982504498 hasLocation W19825044981 @default.
- W1982504498 hasLocation W19825044982 @default.
- W1982504498 hasOpenAccess W1982504498 @default.
- W1982504498 hasPrimaryLocation W19825044981 @default.
- W1982504498 hasRelatedWork W1017745913 @default.
- W1982504498 hasRelatedWork W1133602143 @default.
- W1982504498 hasRelatedWork W2037827363 @default.
- W1982504498 hasRelatedWork W2038667196 @default.
- W1982504498 hasRelatedWork W2254083346 @default.
- W1982504498 hasRelatedWork W2340947775 @default.
- W1982504498 hasRelatedWork W2353805164 @default.